What is Dissemination and Implementation Research?
"Dissemination research is the study of how we can effectively convey evidence and information. Implementation research addresses the challenge of how we can move effective programs, guidelines, interventions and policies into real-world settings so that their potential health benefit for patients and the public at large can be realized."
-National Center for Advancing Translational Sciences (NCATS)
Translational Science Benefits Model
D&I of research evidence should result in measurable improved outcomes in broad domains as outlined in the Translational Science Benefits Model, including clinical and medical, community and public health, economic, and policy and legislative benefits. We will regularly measure impact in these broader categories, including assessment of resource needs and cost of scaling up strategies, and the level of resources required to implement research evidence to reach the least resourced groups of patients, providers, and communities.
- The Translational Science Benefits Model: A NewFramework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences
Learn More about D&I Research
- Training Institute for Dissemination and Implementation Research in Cancer (TIDIRC) OpenAccess (NIH)
- Dissemination and Implementation Research at Colorado Clinical and Translational Sciences Institute
Important D&I Publications and Links
|Dissemination and implementation science resources, training, and scientific activities provided through CTSA programs nationally: Opportunities to advance D&I research and training capacity||Rachel C. Shelton, Rowena J. Dolor , Jonathan Tobin, Ana Baumann, Catherine Rohweder, Sapana Patel and Laura-Mae Baldwin|
|Integrating dissemination and implementation sciences within Clinical and Translational Science Award programs to advance translational research: Recommendations to national and local leaders||Tara G. Mehta, Jane Mahoney, Aaron L. Leppin, Kathleen R. Stevens, Reza Yousefi-Nooraie, Brad H. Pollock, Rachel C. Shelton, Rowena Dolor, Harold Pincus, Sapana Patel, and Justin B. Moore|
|Dissemination and implementation science activities across the Clinical Translational Science Award (CTSA) Consortium: Report from a survey of CTSA leaders||Rowena J. Dolor, Enola Proctor, Kathleen R. Stevens, Leslie R. Boone, Paul Meissner, and Laura-Mae Baldwin|
|Situating dissemination and implementation sciences within and across the translational research spectrum||
Aaron L Leppin, Jane E Mahoney, Kathleen R Stevens, Stephen J Bartels, Laura-Mae Baldwin, Rowena J Dolor, Enola K Proctor, Linda Scholl, Justin B Moore, Ana A Baumann, Catherine L Rohweder, Joan Luby, Paul Meissner
|Writing implementation research grant proposals: ten key ingredients||
Enola K Proctor, Byron J Powell, Ana A Baumann, Ashley M Hamilton, Ryan L Santens
|Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda||Enola Proctor, Hiie Silmere, Ramesh Raghavan, Peter Hovmand, Greg Aarons, Alicia Bunger, Richard Griffey, and Melissa Hensley|
|The PRECIS-2 tool: designing trials that are fit for purpose||
Kirsty Loudon, Shaun Treweek, Frank Sullivan, Gordon F Cheesbrough, Peter Donnan, Kevin E Thorpe, Merrick Zwarenstein
|Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool||
Wynne E. Norton, Kirsty Loudon, David A. Chambers and Merrick Zwarenstein